Related Experiment Videos
Increased T-lymphocyte interleukin-6 binding in patients with multiple sclerosis
P Bongioanni1, S Mosti, M R Romano
1Department of Neurosciences, Section of Neurology; and Institute of Clinical Medicine, University of Pisa, Italy. bongioanni@sssup1.it
European Journal of Neurology
|July 25, 2000
Summary
Multiple sclerosis patients show increased interleukin-6 (IL-6) receptors on T cells, particularly CD4+ T cells. This suggests a role for the IL-6 system in T-cell activation and the immune pathogenesis of multiple sclerosis.
Area of Science:
- Neuroimmunology
- Autoimmune Diseases
- Cytokine Signaling
Background:
- Multiple sclerosis (MS) is a T-cell-mediated autoimmune disorder affecting the central nervous system.
- Interleukin-6 (IL-6) is a cytokine with significant neuroimmune effects, and its receptors are present on lymphocytes and neuroglial cells.
Purpose of the Study:
- To quantify and compare interleukin-6 (IL-6) receptor expression on peripheral blood T lymphocytes in multiple sclerosis (MS) patients versus healthy controls.
- To investigate potential differences in IL-6 receptor expression between stable MS patients and those experiencing relapses.
Main Methods:
- Assay of IL-6 binding on peripheral blood T lymphocytes from MS patients and healthy controls.
- Quantification of IL-6 receptors (Bmax) and binding affinity (Kd) on T cells.
- Subgroup analysis of IL-6 receptor expression on CD4+ and CD8+ T cells.
Main Results:
- T cells from MS patients exhibited significantly higher IL-6 receptor numbers (Bmax) compared to controls.
- IL-6 receptor expression differed significantly between stable MS patients and those in relapse.
- Significantly elevated IL-6 receptors were found on CD4+ T cells in MS patients, while CD8+ T cells showed minimal expression in both groups.
Conclusions:
- Upregulated IL-6 receptor expression on T cells, especially CD4+ T cells, is associated with multiple sclerosis.
- Increased IL-6 binding may contribute to T-cell activation and the immune pathogenesis of MS.
- The enhanced IL-6 system could play a role in antibody-mediated demyelination through its influence on humoral immune responses.